In the context of NSCLC, ILC2s have been shown to be enriched in NSCLC tumor samples and to upregulate PD-1 expression, displaying an increased expression of type 2 cytokines such as IL-4 and IL-13, suggesting these immune cells also contribute to the immunosuppressive environment [61]. This evidence concerns the gene PDCD1 and neoplasm.